POLYPEPTIDE GROUP

polypeptide-group-logo

The PolyPeptide Group is a contract manufacturing organization for peptides and peptide related molecules. A global presence throughout the world assures our clients a reliable supply with the necessary capacity for an uninterrupted service. The Group is one of the world’s largest independent contract manufacturers of therapeutic peptides for the cosmetic, pharmaceutical and veterinary markets employing more than 450 people in six manufacturing sites located in France, India, Scandinavia and the USA. PolyPeptide Group is privately-held organization that manufactures over one third of all approved peptide drug substances (22 of 62 approved products worldwide) accounting for over 25% of the sales of outsourced peptide therapeutics worldwide.

#SimilarOrganizations #People #Event #Website #More

POLYPEPTIDE GROUP

Social Links:

Industry:
Manufacturing

Founded:
1996-01-01

Address:
Baar, Zug, Switzerland

Country:
Switzerland

Website Url:
http://www.polypeptide.com

Total Employee:
1001+

Status:
Active

Contact:
+46 40 366 200

Email Addresses:
[email protected]

Total Funding:
111 M EUR

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API WordPress Amazon Font Awesome IPv6


Similar Organizations

batavia-biosciences-logo

Batavia Biosciences

Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product

fotona-logo

Fotona

Fotona is a manufacturer of high performance lasers for medical, dental, and aesthetic applications.

Current Employees Featured

el-djouhar-rekaÏ_image

El Djouhar RekaÏ
El Djouhar RekaÏ Head of Business Unit Peptide Process Development & Manufacturing @ Polypeptide Group
Head of Business Unit Peptide Process Development & Manufacturing
2020-10-01

jon-holbech-rasmussen_image

Jon Holbech Rasmussen
Jon Holbech Rasmussen Director Global Development @ Polypeptide Group
Director Global Development

trishul-shah_image

Trishul Shah
Trishul Shah Director Business Development and Head of Sales @ Polypeptide Group
Director Business Development and Head of Sales
2019-06-01

not_available_image

Gunnar Stærkær
Gunnar Stærkær Manager Assessment & Technology Global Development @ Polypeptide Group
Manager Assessment & Technology Global Development

jiri-snopek_image

Jiri Snopek
Jiri Snopek Mass Spectrometry Laboratory Manager @ Polypeptide Group
Mass Spectrometry Laboratory Manager

henric-byhlin_image

Henric Byhlin
Henric Byhlin Global Development Manager @ Polypeptide Group
Global Development Manager

per-moller_image

Per Moller
Per Moller Purification Scientist @ Polypeptide Group
Purification Scientist

juan-jose-gonzalez_image

Juan Jose Gonzalez
Juan Jose Gonzalez Chief Executive Officer @ Polypeptide Group
Chief Executive Officer
2023-04-01

Stock Details


Company's stock symbol is SWX:PPGN

Newest Events participated

eurotides-part-of-tides-europe-2017_event_image Participated in EuroTides: Part Of Tides Europe 2017 on 2017-11-07 as sponsor

europeptides-part-of-tides-europe-2017_event_image Participated in EuroPEPTIDES: Part Of Tides Europe 2017 on 2017-11-07 as sponsor

tides-oligonucleotide-and-peptide-therapeutics-2017_event_image Participated in TIDES: Oligonucleotide and Peptide Therapeutics 2017 on 2017-04-30 as sponsor

Key Employee Changes

Date New article
2023-04-03 PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO

Official Site Inspections

http://www.polypeptide.com Semrush global rank: 2.7 M Semrush visits lastest month: 6.48 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Polypeptide Group"

About PolyPeptide Group

PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) which specializes in the development and manufacturing of synthetic peptides and …See details»

Company - Polypeptide

As a Contract Development & Manufacturing Organization (CDMO) focused on peptide- and oligonucleotide-based therapies, we serve pharma and biotech customers around the globe. …See details»

Annual Report 2023 - Polypeptide

1.1.2 Listing and capitalization. PolyPeptide Group AG, with its registered office at Neuhofstrasse 24, 6340 Baar, Switzerland, is a stock corporation (Aktiengesellschaft), in accordance with art. …See details»

PolyPeptide Group - LinkedIn

PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) which specializes in the development and ...See details»

Strategy - Annual Report 2021 - Polypeptide

PolyPeptide is a globally active contract development and manufacturing organization (CDMO) specializing in the manufacturing of peptides used as the active pharmaceutical ingredient …See details»

Annual Report 2022 - Polypeptide

PolyPeptide is a globally active contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of peptides and oligonucleotides used as …See details»

PolyPeptide Group - LinkedIn

PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based …See details»

PolyPeptide Group Company Profile - Office Locations ... - Craft

Oct 29, 2024 PolyPeptide Group is a contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotechnology companies. It produces proprietary …See details»

Investors - Polypeptide

PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) which specializes in the development …See details»

Polypeptide Group - Crunchbase Company Profile

The PolyPeptide Group is a contract manufacturing organization for peptides and peptide related molecules. A global presence throughout the world assures our clients a reliable supply with the necessary capacity for an uninterrupted service.See details»

Corporate governance - Polypeptide

PolyPeptide Sweden Whistleblower Policy – Swedish Download PDF; Make Yourself Heard. At PolyPeptide we strive to remain focused on the needs of our customers and business, while …See details»

Annual Report 2023 - Polypeptide

Three new large agreements concluded in 2023; together with agreement previously announced in December 2022, they have the potential to double PolyPeptide’s revenue 2023 – …See details»

Grow with us - PolyPeptide Group

PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based …See details»

Strategy - Polypeptide

As a multinational company with 1,273 employees at the end of 2023, PolyPeptide fosters an agile, open and collaborative work environment. It continuously develops its organization and …See details»

Annual Report 2022 - Polypeptide

PolyPeptide maintains applicable whistleblower programs through which anybody with knowledge or suspicion of illegal activities or irregularities can report observations confidentially and even …See details»

What Is a Polypeptide? | Bachem

Jul 6, 2024 What is the structure of a polypeptide? The structure of a polypeptide chain is organised at different levels: primary, secondary, tertiary and sometimes quaternary. At the …See details»

Annual Report 2023 - Polypeptide

PolyPeptide follows an integrated approach for the management of environmental, social and governance (ESG) topics that are considered material for its business. As a contract …See details»

Responsibility - Polypeptide

PolyPeptide follows an integrated approach for the management of environmental, social and governance (ESG) topics that are considered material for its business. As a contract …See details»

Annual Report 2022 - Polypeptide

Mar 14, 2023 PolyPeptide was impacted by rising input costs and wage inflation and, particularly in the second half of 2022, by the technical and manufacturing process problems that hindered …See details»